Len Johnson selected as finalist for the EY Entrepreneur Of The Year 2019 Award
October 7, 2019
Len Johnson selected as finalist for the EY Entrepreneur Of The Year 2019 Award
Pioneer’s One-Time Special Cash Dividend Enjoined by Superior Court of California
October 7, 2019
Pioneer’s One-Time Special Cash Dividend Enjoined by Superior Court of California
Taronis Announces Record Date for Spin Off
October 7, 2019
Taronis Announces Record Date for Spin Off
SNC-Lavalin awarded three-year provision of operations and maintenance workforce contract for Shell-operated QGC venture
October 7, 2019
SNC-Lavalin awarded three-year provision of operations and maintenance workforce contract for Shell-operated QGC venture
Viper Energy Partners LP, a Subsidiary of Diamondback Energy, Inc., Launches $400 Million Offering of Senior Notes
October 7, 2019
Viper Energy Partners LP, a Subsidiary of Diamondback Energy, Inc., Launches $400 Million Offering of Senior Notes
Global Coiled Tubing Market Analysis, Trends, and Forecasts 2019-2025
October 7, 2019
Global Coiled Tubing Market Analysis, Trends, and Forecasts 2019-2025
Viper Energy Partners LP, a Subsidiary of Diamondback Energy, Inc., Provides Third Quarter 2019 Production and Acquisition Update
October 7, 2019
Viper Energy Partners LP, a Subsidiary of Diamondback Energy, Inc., Provides Third Quarter 2019 Production and Acquisition Update
Major Drilling to Acquire Norex Drilling Limited
October 7, 2019
Major Drilling to Acquire Norex Drilling Limited
Global Compressor Oil Market Analysis, Trends, and Forecasts 2019-2025
October 7, 2019
Global Compressor Oil Market Analysis, Trends, and Forecasts 2019-2025
Bristow Group’s Plan Of Reorganization Confirmed By Court
October 7, 2019
Bristow Group’s Plan Of Reorganization Confirmed By Court
Summit Therapeutics Reports New Data from Phase 2 Clinical Trial Connecting Ridinilazole’s Microbiome Preservation to Improved Clinical Outcomes for Patients with C. difficile Infection
October 7, 2019
Summit Therapeutics Reports New Data from Phase 2 Clinical Trial Connecting Ridinilazole’s Microbiome Preservation to Improved Clinical Outcomes for Patients with C. difficile Infection
